The treatment of Basal Joint Arthritis & Genital Herpes with vitamins

Basal Joint Arthritis and Genital Herpes: Mitamins custom make quality formulas for the treatment of Basal Joint Arthritis & Genital Herpes with vitamins. A Basal Joint Arthritis & Genital Herpes formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Basal Joint Arthritis and Genital Herpes

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    Potassium
    100
    mg
    3%
    Omega - 3 Fatty Acids
    100
    mg
    *
    Chondroitin Sulfate
    200
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Feverfew Extract
    50
    mg
    *
    American Ginseng Extract
    100
    mg
    *
  • Amount Per Serving
    % DV
    Licorice Extract
    250
    mg
    *
    Maitake Extract
    50
    mg
    *
    Reishi Extract
    50
    mg
    *
    Shiitake Extract
    50
    mg
    *
    L-Lysine
    100
    mg
    *
    Ginger Extract
    100
    mg
    *
    White Willow Extract
    60
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Basal Joint Arthritis and Genital Herpes
Serving Size:4-5

Basal Joint Arthritis and Genital Herpes Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Survival Data In FDA Approval For ERBITUX(R) (Cetuximab) Supports Use As A Single Agent In Patients With Advanced Colorectal Cancer
ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved an update to the ERBITUX(R) (Cetuximab) product labeling to include overall survival data as a single agent in epidermal growth factor inhibitor (EGFR)-expressing metastatic colorectal cancer (mCRC) patients after failure of both irinotecan- and oxaliplatin-based regimens.
Lupus Patients May Benefit From Organ-Transplant Rejection Drug
A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found."We found that an analog of rapamycin is very effective in improving all aspects of the disease in lupus-prone mice," said Dr.
This information concerning the support of Basal Joint Arthritis and Genital Herpes treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments